Regeneron Pharmaceuticals REGN Unveils C5 Complement Pipeline Strategy But Execution Risks Cap NearTerm Upside Lloyds LYG Stock Why Cash Conversion 019 20260427 MPLX MPLX LP Q4 2025 EPS beats forecasts by 87 percent shares dip 041 percent in todays trading